USPatentGranted
B2

Indole carboxamide derivative

Granted 16 Feb 2016 · no office action yet

Life of the patent

8 dated events
⤢ drag to zoom20142016201820202022202420262028203020322034ProsecutionTerm & fees
ProsecutionTerm & feeshover for detail · click to open

Abstract

The present invention relates to indole carboxamide compounds of formula (I) or a salt thereof [structure] wherein R 2 , R 3 , R 4 , R 6 , R 7 , R 8 , R 51 and R 52 have the meanings as indicated herein, and are MT1 and/or MT2 receptor agonists useful for treating and/or preventing urological diseases.

Claims

21 · 1 independent · depth 5
123456789101112131415161718192021
21 granted claims

Classifications

6 codes
IPC · International Patent Classification
Section A — Human necessities
  • A61K31/44
Section C — Chemistry; metallurgy
  • C07D491/052
  • C07D471/04
  • C07D471/02
  • C07D491/048
  • C07D209/42

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomJul 2013Oct 2013Jan 2014Apr 2014Jul 2014Oct 2014Jan 2015Apr 2015Jul 2015Oct 2015Jan 2016Apr 2016USPTOApplicantRequest for continued examinationRequest for continued examination
USPTOApplicanthover for detail · click to open
Pendency
2.6 y
952 days filing → grant
Office actions
0
none on record
Responses
1
2 RCE
Examiner
Heidi Reese
art unit 1625 · TC 1600
Citations: 25 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Priority chain

1 priority documents
›Priority documents — 1
TypeDocumentDate
related publicationUS 20150203505 A123 Jul 2015

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock